市場調查報告書
商品編碼
1494627
普通手術器械市場:按類型、應用和最終用途分類 - 2024-2030 年全球預測General Surgery Devices Market by Type (Adhesion Prevention Products, Disposable Surgical Supplies, Energy-based & Powered Instrument), Application (Audiology, Cardiology, Neurosurgery), End-use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年普通手術器械市場規模為178.4億美元,預計2024年將達到189.4億美元,2030年將達280.4億美元,複合年成長率為6.67%。
一般外科器械是指專門設計用於輔助一般外科手術和程序的儀器和工具。這些器械包括各種工具,例如手術刀、鑷子、剪刀和縫線。此類別還包括更先進的器械,例如使用電能進行切割和止血的電外科器械,以及用於閉合傷口和切口的縫合器械。需要手術介入的慢性疾病的盛行率不斷上升,加上人口老化的加劇,主要推動了市場的發展。此外,開發中國家醫療保健基礎設施的改善和擴大為引進先進手術設備提供了機會。然而,先進手術設備的高成本可能是一個主要障礙,特別是在欠開發中地區。有關醫療設備核准的嚴格規定可能會延遲產品上市並增加開發成本。此外,對能夠減少手術侵入性、縮短恢復時間並併發症減少併發症的設備的需求不斷成長。利用人工智慧和物聯網提高手術精度和效率的智慧手術設備的開拓為市場帶來了重大機會。
主要市場統計 | |
---|---|
基準年[2023] | 178.4億美元 |
預測年份 [2024] | 189.4億美元 |
預測年份 [2030] | 280.4億美元 |
複合年成長率(%) | 6.67% |
區域洞察
由於先進的醫療基礎設施、高昂的醫療成本和不斷的創新,美洲地區普通外科設備的採用率很高。微創手術的顯著趨勢需要精密、複雜的手術器械和設備。美國食品藥物管理局(FDA) 在監管和核准新設備、確保其安全性和有效性方面發揮重要作用。加拿大共用了這個趨勢,兩國政府都積極投資於醫療保健技術研究。歐洲國家受益於完善的醫療保健系統和歐洲藥品管理局 (EMA) 的統一監管。歐洲的需求是由人口老化和高標準的外科護理所推動的。在中東,海灣國家擁有現代化的醫療設施,並大力投資醫療旅遊業,而許多非洲國家則急需基本的外科和醫療基礎設施。亞太地區的特點是經濟快速成長、醫療支出增加和公共衛生意識增強。中國和印度的中產階級不斷壯大,衛生政策不斷改革,一般外科設備具有巨大的市場潛力。日本以其技術力而聞名,在高階設備製造和創新手術技術方面處於領先地位。
FPNV定位矩陣
FPNV 定位矩陣對於評估通用手術器械市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對普通手術器械市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該領域競爭性質的寶貴見解,包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在普通手術器械市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[198 Pages Report] The General Surgery Devices Market size was estimated at USD 17.84 billion in 2023 and expected to reach USD 18.94 billion in 2024, at a CAGR 6.67% to reach USD 28.04 billion by 2030.
General surgery devices refer to a range of instruments and tools specifically designed to assist with operations and procedures commonly performed during general surgery. These devices can include a variety of tools such as scalpels, forceps, scissors, and sutures. Additionally, more advanced equipment, including electrosurgical devices, which use electrical energy to cut or control bleeding, and staple devices, which are used to close wounds or incisions, are considered part of this category. The growth in the prevalence of chronic diseases that require surgical intervention, coupled with a growing aging population, is primarily pushing the market forward. Additionally, improvements and expansions in healthcare infrastructure in developing countries present opportunities for the adoption of advanced surgical devices. However, the high cost of advanced surgical devices can be a significant hindrance, particularly in less developed regions. Stringent regulations governing the approval of medical devices can delay product launches and increase development costs. Furthermore, growing demand for devices that make surgeries less invasive, reduce recovery time, and minimize complications. The development of smart surgical devices that use artificial intelligence and the Internet of Things to offer enhanced precision and efficiency in surgeries poses significant opportunities to the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 17.84 billion |
Estimated Year [2024] | USD 18.94 billion |
Forecast Year [2030] | USD 28.04 billion |
CAGR (%) | 6.67% |
Regional Insights
In the American region, the adoption of general surgery devices is robust due to advanced healthcare infrastructure, high healthcare expenditure, and a constant push for technological innovations. A notable trend towards minimally invasive surgeries demands precise and sophisticated surgical instruments and devices. The U.S. Food and Drug Administration (FDA) plays a crucial role in regulating and approving new devices, ensuring safety and efficacy. Canada shares these trends, with both governments actively investing in healthcare technology research. European countries benefit from well-established healthcare systems and uniform regulations enforced by the European Medicines Agency (EMA). The demand in Europe is driven by an aging population and a high standard of surgical care. In the Middle East region, the Gulf states have modern medical facilities and are investing heavily in medical tourism, whereas many African countries are in urgent need of basic surgical and medical infrastructure. The APAC region is marked by rapid economic growth, increasing healthcare expenditure, and growing public health awareness. China and India, with their burgeoning middle classes and reforms in healthcare policies, show significant market potential for general surgery devices. Japan, known for its technological prowess, leads in high-end device manufacturing and innovative surgical techniques.
Market Insights
The market dynamics represent an ever-changing landscape of the General Surgery Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the General Surgery Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the General Surgery Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
FDA Approval Granted to Virtual Incision's MIRA: The First Miniaturized Robotic-Assisted Surgery System for Colectomies
The U.S. Food and Drug Administration (FDA) authorized the MIRA Surgical System, developed by Virtual Incision. This milestone marks MIRA as the first miniaturized, robotic-assisted surgery (RAS) device specifically approved for use in adult colectomy procedures. MIRA's small, self-contained design enables operation directly within the abdominal cavity without requiring a dedicated operating room or creating extensive setup times. [Published On: 2024-02-24]
RTI Surgical Expands Portfolio with Strategic Acquisition of Cook Biotech
RTI Surgical has officially announced its acquisition of Cook Biotech, a division of Cook Group specializing in biologic grafts. This strategic move aims to enhance RTI Surgical's product offerings and fortify its position in the global surgical devices market. Cook Biotech is renowned for its innovative technologies in regenerative medicine, and its integration under RTI Surgical's umbrella is expected to extend RTI's capabilities in biologic grafts and broaden its influence and reach in the healthcare sector. [Published On: 2024-01-08]
Johnson & Johnson MedTech Announces Launch Schedule for Innovative General Surgery Robot
Johnson & Johnson MedTech has outlined significant details and a launch timeline for its new general surgery robot, marking a pivotal step in advancing surgical technologies. This innovative robotic system is designed to enhance precision in various surgical procedures, thereby potentially improving patient outcomes. [Published On: 2023-11-07]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the General Surgery Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the General Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, and Company, Cardinal Health, Inc., Carl Zeiss Meditec AG, CooperSurgical, Inc., Delta Med S.p.A., Ecolab Inc., Globus Medical, Inc., Henry Schein, Inc., Innomed, Inc., Johnson & Johnson Services Inc, Koninklijke Philips N.V., Medica Europe B.V., Medtronic PLC, Olympus Corporation, Schott AG, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage